283 related articles for article (PubMed ID: 26363869)
1. Design, synthesis and biological evaluation of novel 1,2,4-triazolo [3,4-b][1,3,4] thiadiazines bearing furan and thiophene nucleus.
Zhang B; Li YH; Liu Y; Chen YR; Pan ES; You WW; Zhao PL
Eur J Med Chem; 2015 Oct; 103():335-42. PubMed ID: 26363869
[TBL] [Abstract][Full Text] [Related]
2. Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors.
LaPorte MG; Wang Z; Colombo R; Garzan A; Peshkov VA; Liang M; Johnston PA; Schurdak ME; Sen M; Camarco DP; Hua Y; Pollock NI; Lazo JS; Grandis JR; Wipf P; Huryn DM
Bioorg Med Chem Lett; 2016 Aug; 26(15):3581-5. PubMed ID: 27381083
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activities of new Benzothiadiazinyl Hydrazinecarboxamides and Anilino[1,2,4]triazolo[1,5-b][1,2,4]thiadiazine 5,5-diones.
Kamal A; Srikanth YV; Ashraf M; Khan MN; Shaik TB; Kalivendi SV; Suri N; Saxena AK
Med Chem; 2011 May; 7(3):165-72. PubMed ID: 21486211
[TBL] [Abstract][Full Text] [Related]
4. Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents.
Husain A; Rashid M; Shaharyar M; Siddiqui AA; Mishra R
Eur J Med Chem; 2013 Apr; 62():785-98. PubMed ID: 23333063
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors.
Xu Q; Bao K; Sun M; Xu J; Wang Y; Tian H; Zuo D; Guan Q; Wu Y; Zhang W
Sci Rep; 2017 Sep; 7(1):11997. PubMed ID: 28931885
[TBL] [Abstract][Full Text] [Related]
8. One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties.
Ma WF; Yang HK; Hu MJ; Li Q; Ma TZ; Zhou ZZ; Liu RY; You WW; Zhao PL
Eur J Med Chem; 2014 Sep; 84():127-34. PubMed ID: 25016234
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and pharmacological screening of β-amino-, thiadiazole/thiadiazine-phosphonate based triazole motifs as antimicrobial/cytotoxic agents.
Abdou WM; Ganoub NA; Sabry E
Acta Pharm; 2014 Sep; 64(3):267-84. PubMed ID: 25296674
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
Li YH; Zhang B; Yang HK; Li Q; Diao PC; You WW; Zhao PL
Eur J Med Chem; 2017 Jan; 125():1098-1106. PubMed ID: 27810596
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives.
Xue DQ; Zhang XY; Wang CJ; Ma LY; Zhu N; He P; Shao KP; Chen PJ; Gu YF; Zhang XS; Wang CF; Ji CH; Zhang QR; Liu HM
Eur J Med Chem; 2014 Oct; 85():235-44. PubMed ID: 25086915
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
16. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol.
Lauria A; Abbate I; Patella C; Martorana A; Dattolo G; Almerico AM
Eur J Med Chem; 2013 Apr; 62():416-24. PubMed ID: 23395722
[TBL] [Abstract][Full Text] [Related]
17. In-vitro anti-HIV and antitumor activity of new 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and thiadiazine analogues.
Al-Soud YA; Al-Masoudi NA; Loddo R; La Colla P
Arch Pharm (Weinheim); 2008 Jun; 341(6):365-9. PubMed ID: 18493972
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antiproliferative activity of novel 5-nitropyrimidine-2,4-diamine derivatives bearing alkyl acetate moiety.
Zhao PL; Li YH; Yang HK; Chen P; Zhang B; Sun Q; Li Q; You WW
Eur J Med Chem; 2016 Aug; 118():161-9. PubMed ID: 27128180
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids.
Duan YC; Zheng YC; Li XC; Wang MM; Ye XW; Guan YY; Liu GZ; Zheng JX; Liu HM
Eur J Med Chem; 2013 Jun; 64():99-110. PubMed ID: 23644193
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.
Kamel MM; Megally Abdo NY
Eur J Med Chem; 2014 Oct; 86():75-80. PubMed ID: 25147148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]